TERN

Terns Pharmaceuticals Inc (TERN)

US
$ 2.92-4.26%

Price Chart

Key Statistics

Market Cap
$ 509.18M
P/E Ratio
0.00
Revenue (TTM)
$ 1M
Volume
803.83K
52W High
$ 11.40
52W Low
$ 1.86
Dividend Yield
0.00%
Beta
-0.12

Technicals

50-Day MA
4.3676
200-Day MA
4.6082
52 Week High
11.4
52 Week Low
1.865

About TERN

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

Employees
59
Headquarters
Foster City, CA
CEO
Ms. Amy L. Burroughs M.B.A.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg